Bone marrow derived mesenchymal stem cell therapy (Taiwan Bio Therapeutics)

N/A

Report date: 2024/03/01 11:56:36

Base Information

Drug NameBone marrow derived mesenchymal stem cell therapy (Taiwan Bio Therapeutics)
Drug Alias NameOmniMSC-AMI (Taiwan Bio Therapeutics)Allogeneic Bone Marrow MSC Therapy (Taiwan Bio Therapeutics)Allogenic bone marrow-derived mesenchymal stem cells Therapy (Taiwan Bio Therapeutics)Chondrochymal
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Bio Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Bio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A